Rucker J

Impact of Psilocybin on Motor Function in Healthy Participants: A Phase 1, Randomised, Triple-Blind, Dose-Finding Study.

Bhagavan C, Carter O, Nielsen G +12

ArticleMDMA

Psychodynamic Perspectives on Psychedelic States and Treatment Contexts: A Conceptual and Clinical Introduction.

Modlin NL, Elek Z, Maggio C +5

A systematic review of the pharmacokinetics of classical serotonergic psychedelic compounds in healthy adult subjects.

Hampsey E, Martin K, Kalfas M +5

How to set up a psychedelic study: Unique considerations for research involving human participants.

Glennon MJ, Bird CIV, Yadav P +18

Effects of psilocybin on personality, psychiatric symptoms, and values: Exploring mediating effects of the acute psychedelic experience.

Kerr-Gaffney J, Myrtle S, Askari F +4

PreprintPsilocybin

A Randomised, Triple-Blind, Dose-Finding Study of the Impact of Psilocybin on Motor Function in Healthy Participants

Bhagavan C, Carter O, Nielsen G +12

Investigational psilocybin treatment for post-traumatic stress disorder: a qualitative study of participant experience, trauma engagement, and differences from standard treatment.

Modlin NL, Williamson V, Goodwin GM +10

Psilocybin-assisted physiotherapy for refractory motor functional neurological disorder: protocol for a randomised dose-comparison pilot study.

Bhagavan C, Bryson A, Carter O +13

PreprintPsychedelics

Characterising the clinical associations of hallucinogen persisting perceptual disorder: a retrospective cohort study

Butler M, Moore E, Rucker J +6

Perspectives on Trauma Treatment, Self-Management Strategies, and Attitudes Toward Psychedelic Therapies in Individuals with Psychological Trauma Symptoms.

Modlin NL, Jessica L MK, Sarang M +6

ArticleKetamine

Urological symptoms following ketamine treatment for psychiatric disorders: A systematic review.

Kerr-Gaffney J, Tröger A, Caulfield A +3

Clinical conceptualisation of PTSD in psilocybin treatment: disrupting a pre-determined and over-determined maladaptive interpretive framework.

Modlin NL, Williamson V, Maggio C +4

PreprintPsilocybin

Probing the functional magnetic resonance imaging response to psilocybin in functional neurological disorder (PsiFUND): study protocol

Butler M, Bird C, Maggio C +14

Participants' Experience of Psychedelic Integration Groups and Processes: A Qualitative Thematic Analysis.

Modlin NL, McPhee T, Zazon N +6

Psychedelic-assisted treatment for substance use disorder: A narrative systematic review.

Piper T, Small F, Brown S +5

Adverse psychiatric effects of psychedelic drugs: a systematic review of case reports.

Yildirim B, Sahin SS, Gee A +5

Preclinical models for evaluating psychedelics in the treatment of major depressive disorder.

Alexander L, Anderson D, Baxter L +3

Low-dose psilocybin in short-lasting unilateral neuralgiform headache attacks: results from an open-label phase Ib ascending dose study.

Rucker J, Butler M, Hambleton S +8

PreprintPsilocybin

Probing the functional magnetic resonance imaging response to psilocybin in functional neurological disorder (PsiFUND): study protocol

Butler M, Bird C, Maggio C +14

Psilocybin and Motor Function: A Triple-Blind, Dose-Finding Study in Healthy Participants.

Bhagavan C, Kanaan R, Carter O +13

A rapid narrative review of the clinical evolution of psychedelic treatment in clinical trials.

Kishon R, Modlin NL, Cycowicz YM +5

UK medical students' self-reported knowledge and harm assessment of psychedelics and their application in clinical research: a cross-sectional study.

Song-Smith C, Jacobs E, Rucker J +3

Probing the functional magnetic resonance imaging response to psilocybin in functional neurological disorder (PsiFUND): study protocol.

Butler M, Bird C, Maggio C +14

PreprintPsychedelics

UK medical students’ self-reported knowledge and harm assessment of psychedelics and their application in clinical research: a cross-sectional study

Song-Smith C, Jacobs E, Rucker J +3

Europe PMC2023

Expectancy in placebo-controlled trials of psychedelics: if so, so what?

Butler M, Jelen L, Rucker J

Europe PMC2022

Psilocybin-assisted therapy for the treatment of resistant major depressive disorder (PsiDeR): protocol for a randomised, placebo-controlled feasibility trial.

Rucker J, Jafari H, Mantingh T +7

Europe PMC2021

ArticleDMT

A narrative synthesis of research with 5-MeO-DMT.

Ermakova AO, Dunbar F, Rucker J +1

Europe PMC2022

ArticleKetamine

Cardiovascular Effects of Combining Subcutaneous or Intravenous Esketamine and the MAO Inhibitor Tranylcypromine for the Treatment of Depression: A Retrospective Cohort Study.

Ludwig VM, Sauer C, Young AH +4

Europe PMC2021

Psychedelic treatment of functional neurological disorder: a systematic review.

Butler M, Seynaeve M, Nicholson TR +5

Europe PMC2020